Alendronate
Bisphosphonate- Drug Class
- Bisphosphonate
- Mechanism of Action (MOA)
- Binds hydroxyapatite and inhibits osteoclast-mediated bone resorption → ↑ bone mineral density.
- Clinical Notes
- First-line for osteoporosis. Take on an empty stomach with water and stay upright ≥30 min (pill esophagitis). Osteonecrosis of the jaw and atypical femoral fractures with long-term use.
- Source
- FDA label
Sources
Reviewed September 2026- FDA label — FDA / DailyMed
Checked against the guideline or standard reference the exam keys to. If it has moved, use Report an error below.
Same family
Got a pharmacology lecture that covers Alendronate? Turn it into flashcards and board-style questions, free. Drop it on the home page
All pharmacology